APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Naloxone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Naloxone Market Analysis and Forecast 2026-2032

Report ID 174015560220 December 2025194 pages

Choose your research edition.

Industry ResearchNaloxone Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Naloxone Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Naloxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naloxone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Naloxone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Naloxone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Naloxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Naloxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Naloxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Naloxone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Naloxone include ADAPT Pharma, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Kaleo, West Ward Pharmaceuticals, Pfizer, Mylan and Sandoz, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Naloxone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Naloxone, also provides the sales of main regions and countries. Of the upcoming market potential for Naloxone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Naloxone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Naloxone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Naloxone sales, projected growth trends, production technology, application and end-user industry.

Naloxone Segment by Company

ADAPT Pharma

Amneal Pharmaceuticals

Amphastar Pharmaceuticals

Kaleo

West Ward Pharmaceuticals

Pfizer

Mylan

Sandoz

Naloxone Segment by Type

Spray Forms

Injectable Forms

Naloxone Segment by Application

Hospital Pharmacies

Drug Store

Online

Naloxone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naloxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naloxone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naloxone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Naloxone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Naloxone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Naloxone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Spray Forms Major Manufacturers Table 3. Injectable Forms Major Manufacturers Table 4. Global Naloxone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacies Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Online Major Manufacturers Table 8. Naloxone Industry Trends Table 9. Naloxone Industry Drivers Table 10. Naloxone Industry Opportunities and Challenges Table 11. Naloxone Industry Restraints Table 12. Global Naloxone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Naloxone Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Naloxone Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Naloxone Revenue Market Share by Region (2021-2026) Table 16. Global Naloxone Revenue Market Share by Region (2027-2032) Table 17. Global Naloxone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Naloxone Sales by Region (2021-2026) & (W Units) Table 19. Global Naloxone Sales by Region (2027-2032) & (W Units) Table 20. Global Naloxone Sales Market Share by Region (2021-2026) Table 21. Global Naloxone Sales Market Share by Region (2027-2032) Table 22. Global Naloxone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Naloxone Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Naloxone Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Naloxone Sales Market Share by Manufacturers (2021-2026) Table 26. Global Naloxone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Naloxone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Naloxone Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Naloxone Manufacturers, Product Type & Application Table 30. Global Naloxone Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Naloxone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Naloxone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Naloxone Revenue Market Share by Type (2021-2026) Table 37. Global Naloxone Revenue Market Share by Type (2027-2032) Table 38. Global Naloxone Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Naloxone Sales by Type (2021-2026) & (W Units) Table 40. Global Naloxone Sales by Type (2027-2032) & (W Units) Table 41. Global Naloxone Sales Market Share by Type (2021-2026) Table 42. Global Naloxone Sales Market Share by Type (2027-2032) Table 43. Global Naloxone Price by Type (2021-2026) & (US$/Unit) Table 44. Global Naloxone Price by Type (2027-2032) & (US$/Unit) Table 45. Global Naloxone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Naloxone Revenue Market Share by Application (2021-2026) Table 49. Global Naloxone Revenue Market Share by Application (2027-2032) Table 50. Global Naloxone Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Naloxone Sales by Application (2021-2026) & (W Units) Table 52. Global Naloxone Sales by Application (2027-2032) & (W Units) Table 53. Global Naloxone Sales Market Share by Application (2021-2026) Table 54. Global Naloxone Sales Market Share by Application (2027-2032) Table 55. Global Naloxone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Naloxone Price by Application (2027-2032) & (US$/Unit) Table 57. ADAPT Pharma Company Information Table 58. ADAPT Pharma Business Overview Table 59. ADAPT Pharma Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. ADAPT Pharma Naloxone Product Portfolio Table 61. ADAPT Pharma Recent Development Table 62. Amneal Pharmaceuticals Company Information Table 63. Amneal Pharmaceuticals Business Overview Table 64. Amneal Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Amneal Pharmaceuticals Naloxone Product Portfolio Table 66. Amneal Pharmaceuticals Recent Development Table 67. Amphastar Pharmaceuticals Company Information Table 68. Amphastar Pharmaceuticals Business Overview Table 69. Amphastar Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Amphastar Pharmaceuticals Naloxone Product Portfolio Table 71. Amphastar Pharmaceuticals Recent Development Table 72. Kaleo Company Information Table 73. Kaleo Business Overview Table 74. Kaleo Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Kaleo Naloxone Product Portfolio Table 76. Kaleo Recent Development Table 77. West Ward Pharmaceuticals Company Information Table 78. West Ward Pharmaceuticals Business Overview Table 79. West Ward Pharmaceuticals Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. West Ward Pharmaceuticals Naloxone Product Portfolio Table 81. West Ward Pharmaceuticals Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Naloxone Product Portfolio Table 86. Pfizer Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Naloxone Product Portfolio Table 91. Mylan Recent Development Table 92. Sandoz Company Information Table 93. Sandoz Business Overview Table 94. Sandoz Naloxone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sandoz Naloxone Product Portfolio Table 96. Sandoz Recent Development Table 97. North America Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Naloxone Sales by Type (2021-2026) & (W Units) Table 100. North America Naloxone Sales by Type (2027-2032) & (W Units) Table 101. North America Naloxone Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Naloxone Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Naloxone Sales by Application (2021-2026) & (W Units) Table 106. North America Naloxone Sales by Application (2027-2032) & (W Units) Table 107. North America Naloxone Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Naloxone Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Naloxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Naloxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Naloxone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 113. North America Naloxone Sales by Country (2021-2026) & (W Units) Table 114. North America Naloxone Sales by Country (2027-2032) & (W Units) Table 115. North America Naloxone Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Naloxone Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Naloxone Revenue (2021-2032) & (US$ Million) Table 118. Canada Naloxone Revenue (2021-2032) & (US$ Million) Table 119. Europe Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Naloxone Sales by Type (2021-2026) & (W Units) Table 122. Europe Naloxone Sales by Type (2027-2032) & (W Units) Table 123. Europe Naloxone Sales Price by Type (2021-2026) & (US$/Unit) Table 124. Europe Naloxone Sales Price by Type (2027-2032) & (US$/Unit) Table 125. Europe Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Naloxone Sales by Application (2021-2026) & (W Units) Table 128. Europe Naloxone Sales by Application (2027-2032) & (W Units) Table 129. Europe Naloxone Sales Price by Application (2021-2026) & (US$/Unit) Table 130. Europe Naloxone Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Europe Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Naloxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Naloxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Naloxone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 135. Europe Naloxone Sales by Country (2021-2026) & (W Units) Table 136. Europe Naloxone Sales by Country (2027-2032) & (W Units) Table 137. Europe Naloxone Sales Price by Country (2021-2026) & (US$/Unit) Table 138. Europe Naloxone Sales Price by Country (2027-2032) & (US$/Unit) Table 139. Germany Naloxone Revenue (2021-2032) & (US$ Million) Table 140. France Naloxone Revenue (2021-2032) & (US$ Million) Table 141. U.K. Naloxone Revenue (2021-2032) & (US$ Million) Table 142. Italy Naloxone Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Naloxone Revenue (2021-2032) & (US$ Million) Table 144. China Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 145. China Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 146. China Naloxone Sales by Type (2021-2026) & (W Units) Table 147. China Naloxone Sales by Type (2027-2032) & (W Units) Table 148. China Naloxone Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China Naloxone Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 151. China Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 152. China Naloxone Sales by Application (2021-2026) & (W Units) Table 153. China Naloxone Sales by Application (2027-2032) & (W Units) Table 154. China Naloxone Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China Naloxone Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Naloxone Sales by Type (2021-2026) & (W Units) Table 159. Asia Naloxone Sales by Type (2027-2032) & (W Units) Table 160. Asia Naloxone Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia Naloxone Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Naloxone Sales by Application (2021-2026) & (W Units) Table 165. Asia Naloxone Sales by Application (2027-2032) & (W Units) Table 166. Asia Naloxone Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia Naloxone Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Naloxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Naloxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Naloxone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 172. Asia Naloxone Sales by Country (2021-2026) & (W Units) Table 173. Asia Naloxone Sales by Country (2027-2032) & (W Units) Table 174. Asia Naloxone Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia Naloxone Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan Naloxone Revenue (2021-2032) & (US$ Million) Table 177. South Korea Naloxone Revenue (2021-2032) & (US$ Million) Table 178. India Naloxone Revenue (2021-2032) & (US$ Million) Table 179. Australia Naloxone Revenue (2021-2032) & (US$ Million) Table 180. China Taiwan Naloxone Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Naloxone Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Naloxone Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Naloxone Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Naloxone Sales by Type (2021-2026) & (W Units) Table 185. SAMEA Naloxone Sales by Type (2027-2032) & (W Units) Table 186. SAMEA Naloxone Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA Naloxone Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA Naloxone Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Naloxone Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Naloxone Sales by Application (2021-2026) & (W Units) Table 191. SAMEA Naloxone Sales by Application (2027-2032) & (W Units) Table 192. SAMEA Naloxone Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA Naloxone Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Naloxone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Naloxone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Naloxone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 198. SAMEA Naloxone Sales by Country (2021-2026) & (W Units) Table 199. SAMEA Naloxone Sales by Country (2027-2032) & (W Units) Table 200. SAMEA Naloxone Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA Naloxone Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil Naloxone Revenue (2021-2032) & (US$ Million) Table 203. Argentina Naloxone Revenue (2021-2032) & (US$ Million) Table 204. Chile Naloxone Revenue (2021-2032) & (US$ Million) Table 205. Colombia Naloxone Revenue (2021-2032) & (US$ Million) Table 206. Peru Naloxone Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Naloxone Revenue (2021-2032) & (US$ Million) Table 208. Israel Naloxone Revenue (2021-2032) & (US$ Million) Table 209. UAE Naloxone Revenue (2021-2032) & (US$ Million) Table 210. Turkey Naloxone Revenue (2021-2032) & (US$ Million) Table 211. Iran Naloxone Revenue (2021-2032) & (US$ Million) Table 212. Egypt Naloxone Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Naloxone Distributors List Table 216. Naloxone Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Naloxone Image Figure 2. Global Naloxone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naloxone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Spray Forms Image Figure 5. Injectable Forms Image Figure 6. Global Naloxone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Naloxone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Drug Store Image Figure 10. Online Image Figure 11. Global Naloxone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Naloxone Revenue (2021-2032) & (US$ Million) Figure 13. Global Naloxone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Naloxone Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Naloxone Revenue Market Share by Region (2021-2032) Figure 16. Global Naloxone Sales (2021-2032) & (W Units) Figure 17. Global Naloxone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Naloxone Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Naloxone Sales YoY (2021-2032) & (W Units) Figure 20. Europe Naloxone Sales YoY (2021-2032) & (W Units) Figure 21. China Naloxone Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Naloxone Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Naloxone Sales YoY (2021-2032) & (W Units) Figure 24. Global Naloxone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Naloxone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Naloxone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Naloxone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Naloxone Revenue Market Share by Type (2021-2032) Figure 30. Global Naloxone Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Naloxone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Naloxone Sales Market Share by Type (2021-2032) Figure 33. Global Naloxone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Naloxone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Naloxone Revenue Market Share by Application (2021-2032) Figure 36. Global Naloxone Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Naloxone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Naloxone Sales Market Share by Application (2021-2032) Figure 39. North America Naloxone Revenue Share by Type (2021-2032) Figure 40. North America Naloxone Sales Share by Type (2021-2032) Figure 41. North America Naloxone Revenue Share by Application (2021-2032) Figure 42. North America Naloxone Sales Share by Application (2021-2032) Figure 43. North America Naloxone Revenue Share by Country (2021-2032) Figure 44. North America Naloxone Sales Share by Country (2021-2032) Figure 45. Europe Naloxone Revenue Share by Type (2021-2032) Figure 46. Europe Naloxone Sales Share by Type (2021-2032) Figure 47. Europe Naloxone Revenue Share by Application (2021-2032) Figure 48. Europe Naloxone Sales Share by Application (2021-2032) Figure 49. Europe Naloxone Revenue Share by Country (2021-2032) Figure 50. Europe Naloxone Sales Share by Country (2021-2032) Figure 51. China Naloxone Revenue Share by Type (2021-2032) Figure 52. China Naloxone Sales Share by Type (2021-2032) Figure 53. China Naloxone Revenue Share by Application (2021-2032) Figure 54. China Naloxone Sales Share by Application (2021-2032) Figure 55. Asia Naloxone Revenue Share by Type (2021-2032) Figure 56. Asia Naloxone Sales Share by Type (2021-2032) Figure 57. Asia Naloxone Revenue Share by Application (2021-2032) Figure 58. Asia Naloxone Sales Share by Application (2021-2032) Figure 59. Asia Naloxone Revenue Share by Country (2021-2032) Figure 60. Asia Naloxone Sales Share by Country (2021-2032) Figure 61. SAMEA Naloxone Revenue Share by Type (2021-2032) Figure 62. SAMEA Naloxone Sales Share by Type (2021-2032) Figure 63. SAMEA Naloxone Revenue Share by Application (2021-2032) Figure 64. SAMEA Naloxone Sales Share by Application (2021-2032) Figure 65. SAMEA Naloxone Revenue Share by Country (2021-2032) Figure 66. SAMEA Naloxone Sales Share by Country (2021-2032) Figure 67. Naloxone Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Naloxone Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Spray Forms
  • Injectable Forms
Applications
  • Hospital Pharmacies
  • Drug Store
  • Online
Companies covered
  • ADAPT Pharma
  • Amneal Pharmaceuticals
  • Amphastar Pharmaceuticals
  • Kaleo
  • West Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Naloxone Market by Type
  3. 1.2.1 Global Naloxone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Spray Forms
  5. 1.2.3 Injectable Forms
  6. 1.3 Naloxone Market by Application
  7. 1.3.1 Global Naloxone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Drug Store
  10. 1.3.4 Online
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Naloxone Market Dynamics
  1. 2.1 Naloxone Industry Trends
  2. 2.2 Naloxone Industry Drivers
  3. 2.3 Naloxone Industry Opportunities and Challenges
  4. 2.4 Naloxone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Naloxone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Naloxone Revenue by Region
  3. 3.2.1 Global Naloxone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Naloxone Revenue by Region (2021-2026)
  5. 3.2.3 Global Naloxone Revenue by Region (2027-2032)
  6. 3.2.4 Global Naloxone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Naloxone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Naloxone Sales by Region
  9. 3.4.1 Global Naloxone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Naloxone Sales by Region (2021-2026)
  11. 3.4.3 Global Naloxone Sales by Region (2027-2032)
  12. 3.4.4 Global Naloxone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Naloxone Revenue by Manufacturers
  2. 4.1.1 Global Naloxone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Naloxone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Naloxone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Naloxone Sales by Manufacturers
  6. 4.2.1 Global Naloxone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Naloxone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Naloxone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Naloxone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Naloxone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Naloxone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Naloxone Manufacturers, Product Type & Application
  13. 4.7 Global Naloxone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Naloxone Market CR5 and HHI
  16. 4.8.2 2025 Naloxone Tier 1, Tier 2, and Tier 3
5 Naloxone Market by Type
  1. 5.1 Global Naloxone Revenue by Type
  2. 5.1.1 Global Naloxone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Naloxone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Naloxone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Naloxone Sales by Type
  6. 5.2.1 Global Naloxone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Naloxone Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Naloxone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Naloxone Price by Type
6 Naloxone Market by Application
  1. 6.1 Global Naloxone Revenue by Application
  2. 6.1.1 Global Naloxone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Naloxone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Naloxone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Naloxone Sales by Application
  6. 6.2.1 Global Naloxone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Naloxone Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Naloxone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Naloxone Price by Application
7 Company Profiles
  1. 7.1 ADAPT Pharma
  2. 7.1.1 ADAPT Pharma Company Information
  3. 7.1.2 ADAPT Pharma Business Overview
  4. 7.1.3 ADAPT Pharma Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ADAPT Pharma Naloxone Product Portfolio
  6. 7.1.5 ADAPT Pharma Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Naloxone Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 Amphastar Pharmaceuticals
  14. 7.3.1 Amphastar Pharmaceuticals Company Information
  15. 7.3.2 Amphastar Pharmaceuticals Business Overview
  16. 7.3.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
  18. 7.3.5 Amphastar Pharmaceuticals Recent Developments
  19. 7.4 Kaleo
  20. 7.4.1 Kaleo Company Information
  21. 7.4.2 Kaleo Business Overview
  22. 7.4.3 Kaleo Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kaleo Naloxone Product Portfolio
  24. 7.4.5 Kaleo Recent Developments
  25. 7.5 West Ward Pharmaceuticals
  26. 7.5.1 West Ward Pharmaceuticals Company Information
  27. 7.5.2 West Ward Pharmaceuticals Business Overview
  28. 7.5.3 West Ward Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 West Ward Pharmaceuticals Naloxone Product Portfolio
  30. 7.5.5 West Ward Pharmaceuticals Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Naloxone Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Mylan
  38. 7.7.1 Mylan Company Information
  39. 7.7.2 Mylan Business Overview
  40. 7.7.3 Mylan Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mylan Naloxone Product Portfolio
  42. 7.7.5 Mylan Recent Developments
  43. 7.8 Sandoz
  44. 7.8.1 Sandoz Company Information
  45. 7.8.2 Sandoz Business Overview
  46. 7.8.3 Sandoz Naloxone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sandoz Naloxone Product Portfolio
  48. 7.8.5 Sandoz Recent Developments
8 North America
  1. 8.1 North America Naloxone Market Size by Type
  2. 8.1.1 North America Naloxone Revenue by Type (2021-2032)
  3. 8.1.2 North America Naloxone Sales by Type (2021-2032)
  4. 8.1.3 North America Naloxone Price by Type (2021-2032)
  5. 8.2 North America Naloxone Market Size by Application
  6. 8.2.1 North America Naloxone Revenue by Application (2021-2032)
  7. 8.2.2 North America Naloxone Sales by Application (2021-2032)
  8. 8.2.3 North America Naloxone Price by Application (2021-2032)
  9. 8.3 North America Naloxone Market Size by Country
  10. 8.3.1 North America Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Naloxone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Naloxone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Naloxone Market Size by Type
  2. 9.1.1 Europe Naloxone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Naloxone Sales by Type (2021-2032)
  4. 9.1.3 Europe Naloxone Price by Type (2021-2032)
  5. 9.2 Europe Naloxone Market Size by Application
  6. 9.2.1 Europe Naloxone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Naloxone Sales by Application (2021-2032)
  8. 9.2.3 Europe Naloxone Price by Application (2021-2032)
  9. 9.3 Europe Naloxone Market Size by Country
  10. 9.3.1 Europe Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Naloxone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Naloxone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Naloxone Market Size by Type
  2. 10.1.1 China Naloxone Revenue by Type (2021-2032)
  3. 10.1.2 China Naloxone Sales by Type (2021-2032)
  4. 10.1.3 China Naloxone Price by Type (2021-2032)
  5. 10.2 China Naloxone Market Size by Application
  6. 10.2.1 China Naloxone Revenue by Application (2021-2032)
  7. 10.2.2 China Naloxone Sales by Application (2021-2032)
  8. 10.2.3 China Naloxone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Naloxone Market Size by Type
  2. 11.1.1 Asia Naloxone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Naloxone Sales by Type (2021-2032)
  4. 11.1.3 Asia Naloxone Price by Type (2021-2032)
  5. 11.2 Asia Naloxone Market Size by Application
  6. 11.2.1 Asia Naloxone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Naloxone Sales by Application (2021-2032)
  8. 11.2.3 Asia Naloxone Price by Application (2021-2032)
  9. 11.3 Asia Naloxone Market Size by Country
  10. 11.3.1 Asia Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Naloxone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Naloxone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Naloxone Market Size by Type
  2. 12.1.1 SAMEA Naloxone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Naloxone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Naloxone Price by Type (2021-2032)
  5. 12.2 SAMEA Naloxone Market Size by Application
  6. 12.2.1 SAMEA Naloxone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Naloxone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Naloxone Price by Application (2021-2032)
  9. 12.3 SAMEA Naloxone Market Size by Country
  10. 12.3.1 SAMEA Naloxone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Naloxone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Naloxone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Naloxone Value Chain Analysis
  2. 13.1.1 Naloxone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Naloxone Production Mode & Process
  6. 13.2 Naloxone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Naloxone Distributors
  9. 13.2.3 Naloxone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst